Mission statement · Company scope
“Our mission is to develop and commercialize novel, non-opioid and non-addictive therapies to safely and effectively address the significant unmet medical need of chronic pain.”
In use2019 – now1 sighting
First seenDec 2019Added
Last seenDec 2019Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Innovation · Problem–solution
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 25 words · reading grade 18.1
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_a0b1c53768a839b8
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2019-12-23 · sec_sentence · S-1/A · accession 0001193125-19-322615
View filing ↗0 to compareCompare